Mutations of the B-Raf proto-oncogene (BRAF) are observed in 2% of lung carcinomas, are exclusive to other tumour types and appear mostly in adenocarcinomas, especially of the papillary type (80%) [33]. Here, BRAF is linked to lung carcinoma.